Please Scroll Down to See Forums Below
Bromocriptine?
- Thread starter cougar8
- Start date
Stacemranger
New member
It shouldn't, I beleive it just helps with the prolactin side of things.
Bromo is not hard to find. In fact it's one of the easiest to find just searching online drugs stores that don't need presriptions. But it's overused. 99% of the time there are no prolactin sides from tren. No it will not enhance test effects.
monster2929
New member
yup, unecessary imo
M
Mr.X
Guest
cougar8 said:
Dostinex is the way to go now. I don't touch bromo anymore - yet it will not decrease test effectiveness, so don't worry.
R
racoon_city
Guest
Ulter said:
thank god someone knows the real deal to these drugs. people pop these like candy...bromo is powerfull shit
M
Mr.X
Guest
Dostinex is the way to go, here's some info - less sides and more effective:
In a another clinical trial involving approximately 450 subjects, Dostinex was compared with bromocriptine in treating hyperporlactinemia. In the eight-week, double blind trial, prolactin levels returned to normal in 77% of subjects treated with Dostinex (0.5mg twice weekly) compared to 59% of those treated with bromocriptine (2.5 mg twice-daily). Restoration of menses occurred in 77% of women treated with Dostinex, compared to 70% of those treated with bromocriptine.
Among subjects with galactorrhea (excessive breast milk discharge), the symptom disappeared in 73% of those treated with Dostinex, compared to 56% of 231 subjects taking bromocriptine.
Side Effects:
Clinical studies also showed the safety profile of Dostinex compares favorably to bromocriptine. Just 2% of 221 subjects taking Dostinex discontinued treatment due to side effects during the eight-week study, versus 60% of 231 subjects taking bromocriptine. Nausea is the most common side effect of both drugs. During the eight-week, double-blinded portion of the trial, 29% of subjects experienced nausea with Dostinex compared with 43% of those taking bromocriptine.
Study proves:
• Dostinex is more potent in treating hyperporlactinemia than Bromocriptine
• Dostinex is more potent in treating excessive breast milk discharge than Bromocriptine
• Dostinex side-effects are milder (if any), Parlodel side-effects are more severe and probable
In a another clinical trial involving approximately 450 subjects, Dostinex was compared with bromocriptine in treating hyperporlactinemia. In the eight-week, double blind trial, prolactin levels returned to normal in 77% of subjects treated with Dostinex (0.5mg twice weekly) compared to 59% of those treated with bromocriptine (2.5 mg twice-daily). Restoration of menses occurred in 77% of women treated with Dostinex, compared to 70% of those treated with bromocriptine.
Among subjects with galactorrhea (excessive breast milk discharge), the symptom disappeared in 73% of those treated with Dostinex, compared to 56% of 231 subjects taking bromocriptine.
Side Effects:
Clinical studies also showed the safety profile of Dostinex compares favorably to bromocriptine. Just 2% of 221 subjects taking Dostinex discontinued treatment due to side effects during the eight-week study, versus 60% of 231 subjects taking bromocriptine. Nausea is the most common side effect of both drugs. During the eight-week, double-blinded portion of the trial, 29% of subjects experienced nausea with Dostinex compared with 43% of those taking bromocriptine.
Study proves:
• Dostinex is more potent in treating hyperporlactinemia than Bromocriptine
• Dostinex is more potent in treating excessive breast milk discharge than Bromocriptine
• Dostinex side-effects are milder (if any), Parlodel side-effects are more severe and probable
